Peripheral Neuropathy Trial, Recruiting NCT07596823 Sponsor: Ankara City Hospital Bilkent Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07596823
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have been diagnosed with neuropathic pain (a type of pain caused by nerve damage or nerve problems) based on a doctor's assessment
  • People whose pain scores on specific neuropathic pain questionnaires (called DN4 and/or LANSS) are consistent with neuropathic pain
  • People who are already receiving a sympathetic nerve block as part of their regular medical treatment
  • People who have blood test results available from both before and after treatment
  • People who are able to sign a written consent form agreeing to take part

Who may not be able to join:

  • People under the age of 18
  • People who currently have an active infection or an acute inflammatory condition
  • People with an active cancer diagnosis
  • People with a history of blood or bone marrow disorders
  • People currently taking medications that suppress the immune system or long-term steroid tablets
  • People who have had major surgery or a serious physical injury within the past month
  • People who are pregnant or breastfeeding
  • People with an autoimmune or inflammatory joint/tissue disease (such as lupus or rheumatoid arthritis)
  • People for whom follow-up medical data is not available

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 905337085212

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara City Hospital Bilkent
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
31 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Treatment Response at Month 3

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov